Literature DB >> 15176175

Technology assessment, priority setting, and appropriate care in Dutch health care.

Marc Berg1, Tom van der Grinten, Niek Klazinga.   

Abstract

This article provides a critical analysis of the impact of health technology assessment (HTA) on priority setting in The Netherlands. It describes the limited steering powers of the Dutch government; its complex interactions with insurers, health-care providers, and patients; and the role of HTA in this context as an attempt to rationalize the debate about cost-effectiveness issues. HTA has been drawn upon for decision making on the health insurance package. Also, HTA findings have been linked to the national guideline development programs of the medical community. However, these impacts by no means have been straightforward. We argue that the political nature of the priority-setting debate asks for a broader approach to what constitutes HTA, and how it should be drawn upon in priority setting. Suggestions are made on how to do justice to the social dynamics of decision making and the behavior of stakeholders in health-care systems.

Entities:  

Mesh:

Year:  2004        PMID: 15176175     DOI: 10.1017/s0266462304000765

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

1.  The current status of decision-making procedures and quality assurance in Europe: an overview.

Authors:  L Valerio; W Ricciardi
Journal:  Med Health Care Philos       Date:  2011-11

2.  From recommendation to action: psychosocial factors influencing physician intention to use Health Technology Assessment (HTA) recommendations.

Authors:  Marie-Pierre Gagnon; Emília Sánchez; Joan Mv Pons
Journal:  Implement Sci       Date:  2006-03-31       Impact factor: 7.327

3.  Collective constructions of 'waste': epistemic practices for disinvestment in the context of Dutch social health insurance.

Authors:  Floortje Moes; Eddy Houwaart; Diana Delnoij; Klasien Horstman
Journal:  BMC Health Serv Res       Date:  2019-09-05       Impact factor: 2.655

4.  Systematic review for the development of a pharmaceutical and medical products prioritization framework.

Authors:  Alberto Frutos Pérez-Surio; Mercedes Gimeno-Gracia; Ma Aránzazu Alcácera López; Ma Asunción Sagredo Samanes; Ma Del Puerto Pardo Jario; Ma Del Tránsito Salvador Gómez
Journal:  J Pharm Policy Pract       Date:  2019-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.